Joshua Wilcox
Latest contributions
Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice
17 Nov 2025 – From PCR London Valves 2025
Discover the essential takeaways from the Myval THV series for improving TAVI outcomes. Learn from high-volume operators how pre-procedural planning, imaging, and sizing rationale guide optimal patient management. See step-by-step implantation of the next-gen Myval Octapro+, including the OctaAlign technique, and understand how precise deployment and...
Complex valve-in-valve leaflet modification - LIVE Case
17 Nov 2025 – From PCR London Valves 2025
Watch this LIVE case followed by a recorded case, regarding a 79-year-old male with permanent AF and a history of surgical aortic valve replacement in 2010 (Magna Ease 25) who presented with symptomatic bioprosthetic valve stenosis, normal LV function, and no CAD. A Sapien 3 Ultra...
Featured cases - TAVI in bicuspid valve anatomy (Part 2)
26 Nov 2024 – From PCR London Valves 2024
This session, part of the Featured Cases series from PCR London Valves 2024, focuses on TAVI in bicuspid valve anatomy. Dive into various complex cases, including TAVI in bicuspid type 0 with severe calcification, tailored sizing strategies in bicuspid aortic valve, and the utility of novel...
Innovation for transcatheter tricuspid interventions - LIVE case
24 Nov 2024 – From PCR London Valves 2024
Dive into the world of innovation for transcatheter tricuspid interventions. Discuss the remaining challenges associated with currently available options, capture the central role of imaging guidance, and understand the anatomical selection criteria for transcatheter tricuspid valve replacement. Experience a live case from St. Thomas' Hospital, London,...
Valve performance and durability - Main considerations in selecting the right TAVI valve
20 Nov 2023 – From PCR London Valves 2023
In this session with LIVE case, participants discuss the critical role of valve selection in influencing patient outcomes. The focus includes understanding the latest clinical outcomes of supra-annular TAVI and SAVR, exploring their practical implications. The session also highlights the contribution of novel technology Evolut FX, in...
